Competition of unfractionated heparin and idraparinux on activated partial thromboplastin time and effect of exogenous antithrombin.
Gouin-Thibault
Isabelle
I
Samama
Michel M
MM
D000925:Anticoagulants / Q000378:metabolism* / Q000627:therapeutic use; D000991:Antithrombins / Q000378:metabolism*; D001667:Binding, Competitive; D001777:Blood Coagulation / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D016903:Drug Monitoring / Q000379:methods*; D065427:Factor Xa Inhibitors; D006493:Heparin / Q000378:metabolism* / Q000627:therapeutic use; D006801:Humans; D009844:Oligosaccharides / Q000378:metabolism* / Q000627:therapeutic use; D010314:Partial Thromboplastin Time; D011237:Predictive Value of Tests; D015203:Reproducibility of Results
D000925:Anticoagulants; D000991:Antithrombins; D065427:Factor Xa Inhibitors; D009844:Oligosaccharides; C479958:idraparinux; D006493:Heparin